Dmitry Balyasny’s Wave Life Sciences WVE Stock Holding History

Dmitry Balyasny’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-211,074	Closed	-$1.53M	–	3561
2026 Q1	$1.53M	Buy	+211,074	New	+$2.75M	﹤0.01%	1904
2025 Q4	–	Sell	-18,427	Closed	-$135K	–	3619
2025 Q3	$135K	Buy	+18,427	New	+$149K	﹤0.01%	2772
2024 Q2	–	Sell	-27,541	Closed	-$170K	–	3178
2024 Q1	$170K	Sell	27,541 -61,429	-69%	-$308K	﹤0.01%	2443
2023 Q4	$449K	Buy	88,970 +52,618	+145%	+$281K	﹤0.01%	1998
2023 Q3	$209K	Buy	+36,352	New	+$166K	﹤0.01%	2022
2023 Q2	–	Sell	-30,154	Closed	-$131K	–	2864
2023 Q1	$131K	Buy	30,154 +19,369	+180%	+$88.7K	﹤0.01%	2292
2022 Q4	$75.5K	Buy	+10,785	New	+$49.7K	﹤0.01%	2286
2021 Q3	–	Sell	-390,104	Closed	-$2.6M	–	2482
2021 Q2	$2.6M	Buy	+390,104	New	+$2.55M	0.01%	940
2019 Q1	–	Sell	-19,584	Closed	-$823K	–	1695
2018 Q4	$823K	Buy	19,584 +11,450	+141%	+$509K	0.01%	956
2018 Q3	$407K	Buy	+8,134	New	+$367K	﹤0.01%	1431
2017 Q3	–	Sell	-49,000	Closed	-$911K	–	2118
2017 Q2	$911K	Buy	+49,000	New	+$1.06M	﹤0.01%	1129

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Dmitry Balyasny's WVE Position: Q2 2026 in Review

Dmitry Balyasny sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 211,074 shares — an estimated $1.53M sold.

Dmitry Balyasny first reported a position in WVE in Q2 2017 and held it in 11 quarters. The position peaked at $2.6M in Q2 2021. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Dmitry Balyasny reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 211,074 Wave Life Sciences shares in Q2 2026, an estimated $1.53M.
Dmitry Balyasny first reported a position in Wave Life Sciences in Q2 2017 and held it in 11 quarters.
Dmitry Balyasny's Wave Life Sciences position peaked at $2.6M in Q2 2021.
238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.